BIOCON

On January 5, 2026, Mylan Inc., headquartered in Canonsburg, PA, acquired 9,19,67,019 equity shares of Biocon Limited through a preferential allotment on a private placement basis, as disclosed under Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This acquisition represents 6.88% of Biocon's total share/voting capital and 6.10% of its total diluted share/voting capital. Following the acquisition, Biocon's equity share capital increased to INR 7,54,12,15,940, divided into 1,50,82,43,188 equity shares with a face value of INR 5 each. Mylan Inc. confirmed that it does not belong to Biocon's promoter group, and the shares were acquired solely through preferential allotment.